Patents by Inventor Walter Moos

Walter Moos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR
    Publication number: 20050064530
    Abstract: Compositions and methods are provided for producing adenine nucleotide translocator (ANT) polypeptides and fusion proteins, including the production and use of recombinant expression constructs having a regulated promoter. ANT ligands and compositions and methods for identifying ANT ligands, agents that bind ANT and agents that interact with ANT are also disclosed.
    Type: Application
    Filed: March 14, 2001
    Publication date: March 24, 2005
    Inventors: Christen Anderson, Robert Davis, Tomas Szabo, Soumitra Ghosh, Walter Moos, Yazhong Pei
  • PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR
    Publication number: 20050019835
    Abstract: Compositions and methods are provided for producing adenine nucleotide translocator (ANT) polypeptides and fusion proteins, including the production and use of recombinant expression constructs having a regulated promoter. ANT ligands and compositions and methods for identifying ANT ligands, agents that bind ANT and agents that interact with ANT are also disclosed.
    Type: Application
    Filed: March 14, 2001
    Publication date: January 27, 2005
    Inventors: Christen Anderson, Robert Davis, William Clevenger, Sandra Wiley, Scott Miller, Tomas Szabo, Soumitra Ghosh, Walter Moos, Yazhong Pei
  • PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR
    Publication number: 20050003352
    Abstract: Compositions and methods are provided for producing adenine nucleotide translocator (ANT) polypeptides and fusion proteins, including the production and use of recombinant expression constructs having a regulated promoter. ANT ligands and compositions and methods for identifying ANT ligands, agents that bind ANT and agents that interact with ANT are also disclosed.
    Type: Application
    Filed: March 16, 2001
    Publication date: January 6, 2005
    Inventors: Christen Anderson, Robert Davis, William Clevenger, Sandra Wiley, Scott Miller, Tomas Szabo, Soumitra Ghosh, Walter Moos, Yazhong Pei
  • PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR
    Publication number: 20050003353
    Abstract: Compositions and methods are provided for producing adenine nucleotide translocator (ANT) polypeptides and fusion proteins, including the production and use of recombinant expression constructs having a regulated promoter. ANT ligands and compositions and methods for identifying ANT ligands, agents that bind ANT and agents that interact with ANT are also disclosed.
    Type: Application
    Filed: March 16, 2001
    Publication date: January 6, 2005
    Inventors: Christen Anderson, Robert Davis, William Clevenger, Sandra Wiley, Scott Miller, Tomas Szabo, Soumitra Ghosh, Walter Moos, Yazhong Pei
  • 2,N.sup.6 -disubstituted adenosines, derivatives and methods of use
    Patent number: 4791103
    Abstract: Novel N.sup.6 -substituted adenosines having desirable ratio of affinities at A1 or A2 receptors and highly desirable central nervous system and cardiovascular activities, such as analgesic, antipsychotic, sedative, or antihypertensive as well as immunoinflammatory activity.
    Type: Grant
    Filed: September 5, 1985
    Date of Patent: December 13, 1988
    Assignee: Warner-Lambert Company
    Inventors: Bharat K. Trivedi, Walter Moos, Harriet W. Hamilton, William C. Patt
  • N.sup.6 -tricyclic adenosines for treating hypertension
    Patent number: 4663313
    Abstract: N.sup.6 -Tricyclic adenosines and pharmaceutically acceptable acid addition salts having highly desirable central nervous system and cardiovascular properties, processes for their manufacture and pharmaceutical composition and methods for using said compounds and compositions are described.
    Type: Grant
    Filed: February 3, 1986
    Date of Patent: May 5, 1987
    Assignee: Warner-Lambert Company
    Inventors: James A. Bristol, Walter Moos, Bharat K. Trivedi
  • N.sup.6 -tricyclic adenosines
    Patent number: 4593019
    Abstract: N.sup.6 -Tricyclic adenosines and pharmaceutically acceptable acid addition salts having highly desirable central nervous system and cardiovascular properties, processes for their manufacture and pharmaceutical compositions and methods for using said compounds and compositions are described.
    Type: Grant
    Filed: October 26, 1984
    Date of Patent: June 3, 1986
    Assignee: Warner-Lambert Company
    Inventors: James A. Bristol, Walter Moos, Bharat K. Trivedi
  • N6-(1- and 2-benzocycloalkyl) adenosines
    Patent number: 4501735
    Abstract: N.sup.6 -(1 and 2-Benzocycloalkyl)adenosines and pharmaceutically acceptable acid addition salts having highly desirable central nervous system and cardiovascular properties, process for their manufacture, pharmaceutical compositions and methods for using said compounds and compositions are described.
    Type: Grant
    Filed: December 5, 1983
    Date of Patent: February 26, 1985
    Assignee: Warner-Lambert Company
    Inventors: Bharat Trivedi, Harriet Hamilton, Walter Moos